Background Congenital tracheal malformations are less common than congenital cardiac diseases and surgical repair of these anomalies is complex. We sought to examine the surgical treatment and outcomes in cases of tracheal anomalies presenting with or without associated congenital malformations. Methods We retrospectively reviewed the demographic, clinical, and imaging data of 49 children who underwent surgery for congenital tracheal malformations between August 2013 and September 2017. Data were collected from the hospital records. Results In all, 49 patients (male, 30; female, 19) underwent surgeries at our center. The children were of ages between 3 and 36 months (average: 9.7 months). Associated congenital lesions included sling in31/49 (63%), vascularring: in 2/49; ventriculoseptaldefectin5/49; Fallot’s tetraology in 2/49 (4.1%), and imperforate anus in 3/49 (6.1%). The outcomes of surgery were excellent in 42(85.7%) cases, good in 3 cases, while mortality occurred in 4(8.1%) cases. All cases of tracheal stenosis without any change in tracheobronchial arborization, 10/12 cases of bridge carina, and all cases of tripod carina were reconstructed using the slide tracheoplasty technique. Antetracheal translocation was performed for correction of associated pulmonary sling, without reimplantation of the pulmonary artery. Conclusions Reconstructive surgery is a feasible treatment option for congenital tracheal malformations. Slide tracheoplasty can be safely applied in all cases for the correction of tracheal stenosis. Segment resection was not required for any portion of the trachea. Pulmonary artery translocation is safe and effective for patients with pulmonary artery sling, rather than reimplantation. Mortality was associated with severe cardiac complications.
Background Mechanical injury to the trachea and bronchi may cause mild to severe stenosis requiring surgical intervention for reconstructing the damaged trachea. The location, length, and cause of injury are important factors affecting the surgical outcome. Method We conducted a retrospective study to evaluate the results of reconstructive surgery on noncancerous tracheobronchial lesions in 75 patients aged 5–55 years who had undergone reconstructive tracheobronchial surgery in our hospital from 2009 to 2018. Results The causes of tracheobronchial injury included blunt trauma in 38 patients, sharp penetrating trauma in 24, a postintubation lesion in 6, a post-tracheotomy lesion in 3, tuberculosis in 3, and an adult congenital lesion in one. In 59 cases of a lesion in the trachea, the length of missing segment before reconnection was 1–2 cm in 6 cases, 3 cm in 22, 4 cm in 18, 5 cm in 13, and >5.5 cm in 1 case. The length of the resected segment was <5.5 cm in all survivors, whereas one death occurred when the resected length was approximately 6 cm. Conclusions The length of the resected segment and precision of the surgery are crucial for determining the outcome of surgery.
Objectives: Nowadays, there are numerous ways to configure trocar placements for lobectomy using the Da Vinci Xi system. Cho Ray Hospital conducted robotic video-assisted thoracic surgery (rVATS) lobectomy in July 2018 and obtained satisfactory results. Currently, there is no research on rVATS lobectomy in Vietnam, so we decided to report our initial experiences using rVATS lobectomy in non-small cell lung cancer at our institute. Subjects and methods: rVATS for lobectomy was performed on 79 patients with lung cancer who were treated at Cho Ray Hospital from July 2018 to June 2022. All patients were performed the rVATS lobectomy with triangular port placement. The cardiere, harmonic arms were used as robotic arms in the present study which was further coordinated with thoracic surgical instruments through working support. The early outcomes were: The rate of conversion to open procedure, post-operative complications, and day of post-operation. Results: Out of 79 enrolled patients, the majority of study participants were males and belonged to the 60 - 69 years age group. Most of them had tumor lesions in the left upper lobe, followed by the right upper lobe and right lower lobe, respectively. The mean tumor size was noted to be 3.8 cm. The mean time of operation was 262.2 minutes. The average blood loss was 200 mL. The rate of conversion to open procedure accounted for 8.9%. In intraoperative lymphadenectomy for the mediastinal lymph node, the resection rate was 74.7%. Amongst postoperative complications, prolonged air leak > 7 days was the most common. In the hospital, mortality was found to be 1.3%. Changes in clinical and pathological lymph node assessment via intraoperative lymph node dissection accounted for 32.9%.
Objectives: To evaluate the efficacy of robotic video-assisted thoracic lobectomy (r-VATS) in patients with locally advanced non-small cell lung cancer. Subjects and methods: r-VATS lobectomy was performed in 79 patients with non-small cell lung cancer treated at Cho Ray Hospital from July 2018 to June 2022. We divided 79 patients into two groups: Group 1 consists of 50 patients with tumors < 5 cm in diameter; group 2 consists of 29 patients with tumors ≥ 5 cm in diameter (cT3 and cT4). Results: The mean operative time of the tumor ≥ 5 cm group was longer than that of the other group (273.7 minutes vs. 255.5 minutes); however, the difference was not statistically significant. The rate of conversion to open surgery in group 2 was significantly higher than in group 1 (17.2% vs. 4.0%, p = 0.046). There was no statistically significant difference in post-operative complications in the two groups. There was no significant difference in the survival rate in the two groups (p = 0.272). Conclusion: r-VATS is effective in lobectomy for non-small cell lung cancer ≥ 5 cm in size (cT3 and cT4). With tumor size ≥ 5 cm, the surgical time, the rate of postoperative complications, and the post-operative recurrence rate did not increase; however, the conversion rate to open surgery increased.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.